Aadi Bioscience (FRA:3350) Price-to-Tangible-Book : 0.47 (As of Jun. 06, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience Price-to-Tangible-Book?

As of today (2024-06-06), Aadi Bioscience's share price is €1.58. Aadi Bioscience's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €3.39. Hence, Aadi Bioscience's Price to Tangible Book Ratio of today is 0.47.

The historical rank and industry rank for Aadi Bioscience's Price-to-Tangible-Book or its related term are showing as below:

FRA:3350' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.47 Med: 1.98 Max: 4.17
Current: 0.48

During the past 4 years, Aadi Bioscience's highest Price to Tangible Book Ratio was 4.17. The lowest was 0.47. And the median was 1.98.

FRA:3350's Price-to-Tangible-Book is ranked better than
95.32% of 1218 companies
in the Biotechnology industry
Industry Median: 2.825 vs FRA:3350: 0.48

A closely related ratio is called PB Ratio. As of today, Aadi Bioscience's share price is €1.58. Aadi Bioscience's Book Value per Sharefor the quarter that ended in Mar. 2024 was €3.39. Hence, Aadi Bioscience's P/B Ratio of today is 0.47.

Aadi Bioscience Price-to-Tangible-Book Historical Data

The historical data trend for Aadi Bioscience's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience Price-to-Tangible-Book Chart

Aadi Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

3.67

1.89

0.48

Aadi Bioscience Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial										1.80	1.27	1.02	0.48	0.64

Competitive Comparison of Aadi Bioscience's Price-to-Tangible-Book

For the Biotechnology subindustry, Aadi Bioscience's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aadi Bioscience's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aadi Bioscience's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Aadi Bioscience's Price-to-Tangible-Book falls into.

Aadi Bioscience Price-to-Tangible-Book Calculation

Aadi Bioscience's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	1.58	/	3.389
	=	0.47

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Aadi Bioscience Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Aadi Bioscience (FRA:3350) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

AADI:USA 3350:Germany

Address

17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272

Website

https://www.aadibio.com

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines